Trials / Conditions / Skin Diseases, Infectious

Skin Diseases, Infectious

27 registered clinical trials studyying Skin Diseases, Infectious.

Status	Trial	Sponsor	Phase
Completed	Effect of an Antiseptic Solution on the Skin Microbiome NCT05608382	Center for Innovation and Research Organization	N/A
Completed	Dalbavancin in Real Clinical Practice in Spain NCT04485676	Angelini Farmacéutica	—
Completed	A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts NCT03981822	Verrica Pharmaceuticals Inc.	Phase 2
Completed	Safety, Efficacy, and Pharmacokinetics (PK) of Daptomycin (MK-3009) in Japanese Pediatric Subjects With Compli NCT03643952	Merck Sharp & Dohme LLC	Phase 2
Completed	Cantharidin and Occlusion in Verruca Epithelium NCT03487549	Verrica Pharmaceuticals Inc.	Phase 2
Completed	Skin and Soft Tissue Infection (SSTI) Study NCT02600871	The University of Texas Health Science Center at San Antonio	Phase 4
Completed	Study of Tedizolid Phosphate in Adolescents With Complicated Skin and Soft Tissue Infection (cSSTI) (MK-1986-0 NCT02276482	Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)	Phase 3
Completed	Safety and Efficacy of BAY1192631 in Japanese Patients With Methicillin-resistant Staphylococcus Aureus (MRSA) NCT01967225	Bayer	Phase 3
Completed	Clinical and Economic Outcomes of Ceftaroline Fosamil for ABSSSI Documented or at Risk of MRSA NCT02582203	Wayne State University	Phase 4
Withdrawn	Topical Antibiotics for Prevention of Intensive Care Unit (ICU) Central Line Infections NCT00990392	Fraser Health	N/A
Terminated	Study the Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSS NCT00865280	Paratek Pharmaceuticals Inc	Phase 3
Completed	MRSA Colonization and Control in the Dallas County Jail NCT00785200	University of Chicago	N/A
Completed	Phase 2 Study of TR-701 in Patients With Complicated Skin and Skin Structure Infections NCT00761215	Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)	Phase 2
Completed	Study of Wound Packing After Superficial Skin Abscess Drainage NCT00746109	NYU Langone Health	Phase 4
Completed	Safety and Efficacy Study of Daptomycin in Pediatric Participants (1 to 17 Years-old) With Skin and Skin Struc NCT00711802	Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)	Phase 4
Completed	Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years NCT00488345	Wyeth is now a wholly owned subsidiary of Pfizer	Phase 2
Completed	Study Evaluating the Safety and Efficacy of Tigecycline in Hospitalized Patients With cSSSI NCT00488761	Wyeth is now a wholly owned subsidiary of Pfizer	Phase 4
Completed	Utility of Trimethoprim-sulfamethoxazole Use in Skin Abscess Management NCT00679302	St. Louis University	Phase 4
Terminated	Efficacy and Safety of Daptomycin Versus Vancomycin or Teicoplanin for Treatment of Complicated Skin and Soft NCT00430937	Novartis Pharmaceuticals	Phase 3
Completed	Effective Antibiotic Treatment of MRSA NCT00388310	Christiana Care Health Services	N/A
Completed	Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections NCT00210899	Basilea Pharmaceutica	Phase 3
Completed	AUGMENTIN 1gm In Skin And Soft Tissue Infection NCT00343135	GlaxoSmithKline	Phase 4
Completed	Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections NCT00228982	Basilea Pharmaceutica	Phase 3
Completed	Effect of Chlorhexidine Skin Cleansing on Skin Flora NCT00198679	Johns Hopkins Bloomberg School of Public Health	Phase 4
Completed	Study Comparing Tigecycline and Vancomycin With Aztreonam in Complicated Skin and Skin Structure Infections NCT00228410	Wyeth is now a wholly owned subsidiary of Pfizer	Phase 3
Completed	A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Oral Ciprofloxacin in the Treatment NCT00257062	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	Phase 3
Completed	A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Oral Ciprofloxacin in the Treatment NCT00257036	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	Phase 2 / Phase 3